Release Date: 06/01/16 14:31 Summary: Becoming a substantial holder from CBA Price Sensitive: No Download Document 1.03MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%